🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Genetic methods

Found 2238 matching trials

Contribution of Optical Genome Mapping (OGM) in the Diagnosis of Multiple Congenital Malformations With or Without Intellectual Disability Without Genetic Abnormality

Congenital malformations result from an embryonic or foetal developmental d...

Status

Recruiting

Location

CHU clermont-Ferrand

Start Date

2025-11-18

Trial ID

NCT07370792

Treatments Being Tested

blood sample

Algorithm for Cervix Carcinoma Screening in CZ Using the Detection of HPV DNA and CINtec Plus

N/A

Cervix carcinoma has been a serious, long-term issue in the Czech Republic....

Status

Completed

Location

Aeskulab Patologie, ks

Start Date

2017-09-01

Trial ID

NCT05578833

Treatments Being Tested

HPV DNA test with selective HPV 16/18 genotyping (cobas® 4800 HPV Test, Roche)p16 and Ki-67 biomarker detection in the form of dual cytological staining (CINtec Plus, Roche)standard conventional cytology PAP test

Study on the Relative Dose Intensity of PARP Inhibitors in Real-life on a Population of Patients Over 70 Years With Advanced Ovarian Cancer

N/A

Poly(ADP-ribose) polymerase (PARP) inhibitors are anti-cancer treatments th...

Status

Recruiting

Location

Centre Hospitalier Universitaire d'Amiens Picardie Site Sud

Start Date

2024-09-24

Trial ID

NCT06572735

Treatments Being Tested

QoL surveys Geriatric assessment (G-CODE)Blood sampling

Influence of Genotype of CYP2C9 on Clinical Efficacy and Pharmacokinetics of Piroxicam After Lower Third Molar Surgery

PHASE4

Pharmacogenetics is an area of Pharmacology that studies the contribution o...

Status

Completed

Location

Multiple Locations

Start Date

2012-10

Trial ID

NCT02450487

Treatments Being Tested

Piroxicam

Developing Biomarkers of Dietary Intake

PHASE1

Background: \- Researchers who study health and nutrition are interested i...

Status

Completed

Location

NIDDK, Phoenix

Start Date

2010-10-24

Trial ID

NCT01237093

Treatments Being Tested

1. Meat, no fish or soda 2. Meat and soda, no fish 3. Meat and fish, no soda 4. Meat and fish and soda 5. Fish, no meat or soda 6. Fish and soda, no meat 7. No meat, fish or soda 8. Soda, no meat or fish

Study of the Safety and Effectiveness of Collagen Cross-Linking at an Irradiance of 9 mW/cm2 and 18 mW/cm2

PHASE1

The primary objective of this study is to determine the effectiveness and s...

Status

Unknown

Location

Mack Eye Center

Start Date

2013-10

Trial ID

NCT02009709

Treatments Being Tested

Riboflavin 0.1% ophthalmic solution CCL-VARIO UV lamp CCL-VARIO at 18 mW/cm2

Studying Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers

N/A

RATIONALE: Studying samples of DNA in the laboratory from women who are BRC...

Status

Unknown

Location

Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office

Start Date

2008-04

Trial ID

NCT00897455

Treatments Being Tested

DNA analysis mutation analysis polymorphism analysis laboratory biomarker analysis evaluation of cancer risk factors

What Benefit of a Full Analysis of Exome? Routine Care Study in Patients With Solid Tumors

N/A

The management of cancers and their therapeutic guidance was until shortly ...

Status

Completed

Location

CGFL

Start Date

2016-05-15

Trial ID

NCT02840604

Community Genetic Navigation Engagement Specialists to Increase Knowledge About Colorectal Cancer Genetics in Hispanic/Latino/a Communities

This clinical trial tests how well an educational program for training Hisp...

Status

Active Not Recruiting

Location

Los Angeles General Medical Center

Start Date

2023-06-23

Trial ID

NCT07276048

Treatments Being Tested

Discussion Educational Intervention Educational Intervention Interview Survey Administration

Imatinib Mesylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Who Have Received Chemotherapy

PHASE2

RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...

Status

Completed

Location

Roswell Park Cancer Institute

Start Date

2008-10

Trial ID

NCT00509093

Treatments Being Tested

imatinib mesylate gene expression analysis mutation analysis polymerase chain reaction flow cytometry biopsy

Previous Next